Table of Contents Table of Contents Introduction Thromboembolism - Overview Thromboembolism - Therapeutics Development Thromboembolism - Therapeutics Assessment Thromboembolism - Companies Involved in Therapeutics Development Thromboembolism - Drug Profiles Thromboembolism - Dormant Projects Thromboembolism - Discontinued Products Thromboembolism - Product Development Milestones Appendix

List of Tables Number of Products under Development for Thromboembolism, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products under Development by Universities/Institutes, H1 2019 Products under Development by Companies, H1 2019 Products under Development by Universities/Institutes, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Thromboembolism - Pipeline by Accu-Break Pharmaceuticals Inc, H1 2019 Thromboembolism - Pipeline by Bayer AG, H1 2019 Thromboembolism - Pipeline by China Biologic Products Inc, H1 2019 Thromboembolism - Pipeline by Daiichi Sankyo Co Ltd, H1 2019 Thromboembolism - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2019 Thromboembolism - Pipeline by F. Hoffmann-La Roche Ltd, H1 2019 Thromboembolism - Pipeline by GC Pharma, H1 2019 Thromboembolism - Pipeline by Ionis Pharmaceuticals Inc, H1 2019 Thromboembolism - Pipeline by Johnson & Johnson, H1 2019 Thromboembolism - Pipeline by Laboratorios Farmaceuticos Rovi SA, H1 2019 Thromboembolism - Pipeline by Portola Pharmaceuticals Inc, H1 2019 Thromboembolism - Pipeline by Tasly Pharmaceutical Group Co Ltd, H1 2019 Thromboembolism - Pipeline by Tetherex Pharmaceuticals Corp, H1 2019 Thromboembolism - Pipeline by Verseon Corp, H1 2019 Thromboembolism - Dormant Projects, H1 2019 Thromboembolism - Dormant Projects, H1 2019 (Contd..1), H1 2019 Thromboembolism - Discontinued Products, H1 2019List of Figures Number of Products under Development for Thromboembolism, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products by Top 10 Targets, H1 2019 Number of Products by Stage and Top 10 Targets, H1 2019 Number of Products by Top 10 Mechanism of Actions, H1 2019 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019 Number of Products by Routes of Administration, H1 2019 Number of Products by Stage and Routes of Administration, H1 2019 Number of Products by Top 10 Molecule Types, H1 2019 Number of Products by Stage and Top 10 Molecule Types, H1 2019

Accu-Break Pharmaceuticals Inc Bayer AG China Biologic Products Inc Daiichi Sankyo Co Ltd Dong-A Socio Holdings Co Ltd F. Hoffmann-La Roche Ltd GC Pharma Ionis Pharmaceuticals Inc Johnson & Johnson Laboratorios Farmaceuticos Rovi SA Portola Pharmaceuticals Inc Tasly Pharmaceutical Group Co Ltd Tetherex Pharmaceuticals Corp Verseon Corp